1. Home
  2. VTSI vs MRNS Comparison

VTSI vs MRNS Comparison

Compare VTSI & MRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTSI
  • MRNS
  • Stock Information
  • Founded
  • VTSI 1993
  • MRNS 2003
  • Country
  • VTSI United States
  • MRNS United States
  • Employees
  • VTSI N/A
  • MRNS N/A
  • Industry
  • VTSI Miscellaneous manufacturing industries
  • MRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • VTSI Consumer Discretionary
  • MRNS Health Care
  • Exchange
  • VTSI Nasdaq
  • MRNS Nasdaq
  • Market Cap
  • VTSI 70.9M
  • MRNS 104.7M
  • IPO Year
  • VTSI N/A
  • MRNS 2014
  • Fundamental
  • Price
  • VTSI $6.48
  • MRNS $0.31
  • Analyst Decision
  • VTSI Strong Buy
  • MRNS Buy
  • Analyst Count
  • VTSI 2
  • MRNS 12
  • Target Price
  • VTSI $14.50
  • MRNS $4.56
  • AVG Volume (30 Days)
  • VTSI 62.2K
  • MRNS 5.7M
  • Earning Date
  • VTSI 11-12-2024
  • MRNS 11-05-2024
  • Dividend Yield
  • VTSI N/A
  • MRNS N/A
  • EPS Growth
  • VTSI 52.41
  • MRNS N/A
  • EPS
  • VTSI 0.63
  • MRNS N/A
  • Revenue
  • VTSI $31,848,960.00
  • MRNS $30,263,000.00
  • Revenue This Year
  • VTSI N/A
  • MRNS $21.18
  • Revenue Next Year
  • VTSI $28.48
  • MRNS $56.42
  • P/E Ratio
  • VTSI $10.18
  • MRNS N/A
  • Revenue Growth
  • VTSI N/A
  • MRNS 16.56
  • 52 Week Low
  • VTSI $4.57
  • MRNS $0.26
  • 52 Week High
  • VTSI $17.68
  • MRNS $11.26
  • Technical
  • Relative Strength Index (RSI)
  • VTSI 56.57
  • MRNS 21.75
  • Support Level
  • VTSI $6.28
  • MRNS $0.29
  • Resistance Level
  • VTSI $6.70
  • MRNS $1.96
  • Average True Range (ATR)
  • VTSI 0.25
  • MRNS 0.12
  • MACD
  • VTSI 0.04
  • MRNS -0.18
  • Stochastic Oscillator
  • VTSI 77.03
  • MRNS 2.41

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company includes installation, training, limited warranties, service agreements and related support. The company sells and supports use of force training and marksmanship firearms training systems and accessories for law enforcement, military or civilian use. The product line of the company includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire and other accessories.

About MRNS Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

Share on Social Networks: